Author:
Pastore D,Specchia G,Mestice A,Liso A,Pannunzio A,Carluccio P,Buquicchio C,Greco G,Ciuffreda L,Pietrantuono G,Liso V
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference30 articles.
1. Gratwohl A, Passweg J, Baldomero H et al. Blood marrow transplantation activity in Europe 1997: European Group for Blood Marrow Transplantation (EBMT). Bone Marrow Transplant 1999; 24: 231–245.
2. Korbling M, Fliedner TM, Holle R et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hematopoietic reconstitution and disease free survival. Bone Marrow Transplant 1991; 7: 343–349.
3. Sanz MA, De la Rubia J, Sanz GF et al. Busulfan plus cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukaemia in first complete remission: a report from a single institution. J Clin Oncol 1993; 11: 1661–1667.
4. De la Rubia J, Sanz JF, Martin G et al. Autologous blood stem cell transplantation for acute myeloblastic leukaemia in first complete remission: intensification therapy before transplantation does not prolong disease-free survival. Haematologica 1999; 84: 125–132.
5. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplant, autologous bone marrow transplant and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277–284.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献